Procollagen production and procollagen messenger RNA levels and activity in human lung fibroblasts during periods of rapid and stationary growth. 1981

P Tolstoshev, and R A Berg, and S I Rennard, and K H Bradley, and B C Trapnell, and R G Crystal

The production of procollagen molecules by human diploid fetal lung fibroblasts (HFL-1 cells) remains constant in both rapid and stationary growth phases. However, log phase cells degrade 3-fold more newly synthesized collagen inside the cell prior to secretion than do stationary phase cells. Procollagen mRNA levels, measured by hybridization with a type I procollagen mRNA-specific complementary DNA, are approximately 2-fold higher in confluent cells than in log phase cells. There are no significant differences in the ability of either log phase or confluent HFL-1 cell procollagen mRNA to be translated in an in vitro cell-free translation system. Therefore, the ability of HFL-1 cells to maintain constant collagen production irrespective of the growth status of the cells results from the combined action of a number of regulatory mechanisms, including changes in procollagen mRNA levels, the utilization of procollagen mRNA, and intracellular procollagen degradation.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D009693 Nucleic Acid Hybridization Widely used technique which exploits the ability of complementary sequences in single-stranded DNAs or RNAs to pair with each other to form a double helix. Hybridization can take place between two complimentary DNA sequences, between a single-stranded DNA and a complementary RNA, or between two RNA sequences. The technique is used to detect and isolate specific sequences, measure homology, or define other characteristics of one or both strands. (Kendrew, Encyclopedia of Molecular Biology, 1994, p503) Genomic Hybridization,Acid Hybridization, Nucleic,Acid Hybridizations, Nucleic,Genomic Hybridizations,Hybridization, Genomic,Hybridization, Nucleic Acid,Hybridizations, Genomic,Hybridizations, Nucleic Acid,Nucleic Acid Hybridizations
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011347 Procollagen A biosynthetic precursor of collagen containing additional amino acid sequences at the amino-terminal and carboxyl-terminal ends of the polypeptide chains. Protocollagen,Procollagen Type M
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D005260 Female Females
D005333 Fetus The unborn young of a viviparous mammal, in the postembryonic period, after the major structures have been outlined. In humans, the unborn young from the end of the eighth week after CONCEPTION until BIRTH, as distinguished from the earlier EMBRYO, MAMMALIAN. Fetal Structures,Fetal Tissue,Fetuses,Mummified Fetus,Retained Fetus,Fetal Structure,Fetal Tissues,Fetus, Mummified,Fetus, Retained,Structure, Fetal,Structures, Fetal,Tissue, Fetal,Tissues, Fetal
D005347 Fibroblasts Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules. Fibroblast

Related Publications

P Tolstoshev, and R A Berg, and S I Rennard, and K H Bradley, and B C Trapnell, and R G Crystal
May 1990, Archives of dermatology,
P Tolstoshev, and R A Berg, and S I Rennard, and K H Bradley, and B C Trapnell, and R G Crystal
September 1981, The Journal of biological chemistry,
P Tolstoshev, and R A Berg, and S I Rennard, and K H Bradley, and B C Trapnell, and R G Crystal
March 1981, Cancer research,
P Tolstoshev, and R A Berg, and S I Rennard, and K H Bradley, and B C Trapnell, and R G Crystal
September 1998, American journal of respiratory cell and molecular biology,
P Tolstoshev, and R A Berg, and S I Rennard, and K H Bradley, and B C Trapnell, and R G Crystal
August 1977, Proceedings of the National Academy of Sciences of the United States of America,
P Tolstoshev, and R A Berg, and S I Rennard, and K H Bradley, and B C Trapnell, and R G Crystal
April 1977, Proceedings of the National Academy of Sciences of the United States of America,
P Tolstoshev, and R A Berg, and S I Rennard, and K H Bradley, and B C Trapnell, and R G Crystal
November 1972, Proceedings of the National Academy of Sciences of the United States of America,
P Tolstoshev, and R A Berg, and S I Rennard, and K H Bradley, and B C Trapnell, and R G Crystal
April 1987, The Journal of clinical investigation,
P Tolstoshev, and R A Berg, and S I Rennard, and K H Bradley, and B C Trapnell, and R G Crystal
November 1991, Cornea,
P Tolstoshev, and R A Berg, and S I Rennard, and K H Bradley, and B C Trapnell, and R G Crystal
April 1988, The Journal of investigative dermatology,
Copied contents to your clipboard!